Exchange: NYSEMkt·Updated 02:47 PM EDT

PLX Earnings

Latest Earnings Results: Q2 '26

Reported: Aug 12

Estimated EPS

-$0.01

Reported EPS

$0.05

Surprise

+600%

Estimated Rev

$12.95M

Reported Rev

$19.9M

Surprise

+53.64%

Protalix BioTherapeutics reported total revenue of $19.9 million for the three months ended June 30, 2026, with net income of $3.8 million, up from $0.2 million in the prior year period.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.02
--
--
N/A
Q2 '26
-$0.01
$0.05
600.00%
BEAT
Q1 '26
-$0.01
$0.22
2300.00%
BEAT
Q4 '25
$0.04
-$0.06
-250.00%
MISSED
Q3 '25
$0.05
$0.03
-45.45%
MISSED

Advertisement|Remove ads.